{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:47:13Z","timestamp":1793828833440,"version":"4.6.1"},"reference-count":30,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,24]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Recent guidelines have recommended a reduced role for primary prevention aspirin use, which is associated with an increased bleeding risk. This study aimed to characterize guideline-discordant aspirin use among adults in a community care setting. As part of a quality improvement initiative, patients at 1 internal medicine and 1 family medicine clinic affiliated with an academic hospital were sent an electronic survey. Patients were included if they were at least 40 years old, had a primary care provider at the specified site, and were seen in the last year. Patients were excluded if they had an indication for aspirin other than primary prevention. Responses were collected from 15 February to 16 March 2022. Analyses were performed to identify predictors of primary prevention aspirin use and predictors of guideline-discordant aspirin use; aspirin users and nonusers were compared using Fisher exact test, independent samples t tests, and multivariable logistic regression. Of the 1460 patients sent a survey, 668 (45.8%) responded. Of the respondents, 132 (24.1%) reported aspirin use that was confirmed to be for primary prevention. Overall, 46.2% to 58.3% of primary prevention aspirin users were potentially taking aspirin, contrary to the guideline recommendations. Predictors of discordant aspirin use included a history of diabetes mellitus and medication initiation by a primary care provider. In conclusion, primary prevention aspirin use may be overutilized and discordant with recent guideline recommendations for approximately half of the patients, suggesting a need for aspirin deimplementation. These efforts may be best focused at the primary care level.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024014220","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T16:21:30Z","timestamp":1734020490000},"page":"6207-6214","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["Guideline concordance of aspirin use for primary prevention in adult outpatients"],"prefix":"10.1182","volume":"8","author":[{"given":"Naina","family":"Chipalkatti","sequence":"first","affiliation":[{"name":"1Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey D.","family":"Barnes","sequence":"additional","affiliation":[{"name":"2Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Bashaw","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Davie","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1598-4562","authenticated-orcid":false,"given":"Jennifer J.","family":"Griggs","sequence":"additional","affiliation":[{"name":"3Division of Hematology\/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI"},{"name":"4Department of Health Management & Policy, University of Michigan, Ann Arbor, MI"},{"name":"5Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Harrod","sequence":"additional","affiliation":[{"name":"6Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob E.","family":"Kurlander","sequence":"additional","affiliation":[{"name":"5Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI"},{"name":"6Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI"},{"name":"7Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Medaugh","sequence":"additional","affiliation":[{"name":"8Department of Family Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Packard","sequence":"additional","affiliation":[{"name":"9Health Information Technology & Services, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6756-3524","authenticated-orcid":false,"given":"Corey","family":"Powell","sequence":"additional","affiliation":[{"name":"10Consulting for Statistics, Computing & Analytics Research, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Sood","sequence":"additional","affiliation":[{"name":"3Division of Hematology\/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Spranger","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9828-9759","authenticated-orcid":false,"given":"Sarah E.","family":"Vordenberg","sequence":"additional","affiliation":[{"name":"11Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7166-386X","authenticated-orcid":false,"given":"Jordan K.","family":"Schaefer","sequence":"additional","affiliation":[{"name":"3Division of Hematology\/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"issue":"10186","key":"2024122313404905000_bib1","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)30541-0","article-title":"The rise and fall of aspirin in the primary prevention of cardiovascular disease","volume":"393","author":"Raber","year":"2019","journal-title":"Lancet"},{"issue":"16","key":"2024122313404905000_bib2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.2022.4983","article-title":"Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force Recommendation Statement","volume":"327","author":"US Preventive Services Task Force","year":"2022","journal-title":"JAMA"},{"key":"2024122313404905000_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2022.3385","volume-title":"Aspirin use to prevent cardiovascular disease and colorectal cancer: an updated decision analysis for the US Preventive Services Task Force","author":"Dehmer","year":"2022"},{"issue":"16","key":"2024122313404905000_bib4","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jama.2022.3385","article-title":"Aspirin use to prevent cardiovascular disease and colorectal cancer: updated modeling study for the US Preventive Services Task Force","volume":"327","author":"Dehmer","year":"2022","journal-title":"JAMA"},{"issue":"11","key":"2024122313404905000_bib5","first-page":"e563","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"10152","key":"2024122313404905000_bib6","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"issue":"16","key":"2024122313404905000_bib7","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","author":"ASCEND Study Collaborative Group","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"2024122313404905000_bib8","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2024122313404905000_bib9","doi-asserted-by":"crossref","first-page":"100197","DOI":"10.1016\/j.jacadv.2022.100197","article-title":"Aspirin with or without statin in individuals without atherosclerotic cardiovascular disease across risk categories","volume":"2","author":"Khan","year":"2023","journal-title":"JACC Adv"},{"issue":"34","key":"2024122313404905000_bib10","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"2","key":"2024122313404905000_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cjca.2023.10.013","article-title":"Canadian Cardiovascular Society\/Canadian Association of Interventional Cardiology 2023 focused update of the guidelines for the use of antiplatelet therapy","volume":"40","author":"Bainey","year":"2024","journal-title":"Can J Cardiol"},{"key":"2024122313404905000_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2147\/CLEP.S72032","article-title":"Aspirin overutilization for the primary prevention of cardiovascular disease","volume":"6","author":"VanWormer","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"8","key":"2024122313404905000_bib13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/M19-0953","article-title":"Prevalence of aspirin use for primary prevention of cardiovascular disease in the United States: results from the 2017 National Health Interview Survey","volume":"171","author":"O'Brien","year":"2019","journal-title":"Ann Intern Med"},{"key":"2024122313404905000_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pmedr.2016.12.023","article-title":"Recent trends in the prevalence of low-dose aspirin use for primary and secondary prevention of cardiovascular disease in the United States, 2012-2015","volume":"5","author":"Stuntz","year":"2017","journal-title":"Prev Med Rep"},{"issue":"5","key":"2024122313404905000_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.amepre.2014.11.005","article-title":"Aspirin use among adults in the U.S.: results of a national survey","volume":"48","author":"Williams","year":"2015","journal-title":"Am J Prev Med"},{"issue":"5","key":"2024122313404905000_bib16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1055\/s-0039-1687905","article-title":"Primary prevention of cardiovascular events with aspirin: toward more harm than benefit-a systematic review and meta-analysis","volume":"45","author":"Christiansen","year":"2019","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"2024122313404905000_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.2018.20578","article-title":"Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis","volume":"321","author":"Zheng","year":"2019","journal-title":"JAMA"},{"issue":"8","key":"2024122313404905000_bib18","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/jamaneurol.2019.1120","article-title":"Frequency of intracranial hemorrhage with low-dose aspirin in individuals without symptomatic cardiovascular disease: a systematic review and meta-analysis","volume":"76","author":"Huang","year":"2019","journal-title":"JAMA Neurol"},{"issue":"7","key":"2024122313404905000_bib19","doi-asserted-by":"crossref","first-page":"e2326237","DOI":"10.1001\/jamanetworkopen.2023.26237","article-title":"Accuracy of electronic health record-documented aspirin for primary prevention in adult outpatients","volume":"6","author":"Chipalkatti","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2024122313404905000_bib20","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/pds.4783","article-title":"Assessment of ICD-10-CM code assignment validity for case finding of outpatient anticoagulant-related bleeding among Medicare beneficiaries","volume":"28","author":"Shehab","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"2024122313404905000_bib21","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.2019001605","article-title":"How I assess and manage the risk of bleeding in patients treated for venous thromboembolism","volume":"135","author":"Klok","year":"2020","journal-title":"Blood"},{"issue":"suppl 1","key":"2024122313404905000_bib22","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.2337\/dc23-S010","article-title":"10. Cardiovascular disease and risk management: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"9","key":"2024122313404905000_bib23","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.123.065420","article-title":"Outcomes after aspirin discontinuation among baseline users in contemporary primary prevention aspirin trials: a meta-analysis","volume":"149","author":"Campbell","year":"2024","journal-title":"Circulation"},{"issue":"10","key":"2024122313404905000_bib24","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.amjcard.2005.01.049","article-title":"Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials","volume":"95","author":"Serebruany","year":"2005","journal-title":"Am J Cardiol"},{"key":"2024122313404905000_bib25","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.2147\/IJGM.S384375","article-title":"Outcomes associated with 50\u00a0mg\/d and 100\u00a0mg\/d aspirin for the prevention and management of cardiovascular disease in chinese elderly: single-center interim analysis of a multicenter, prospective, observational study","volume":"15","author":"Wang","year":"2022","journal-title":"Int J Gen Med"},{"issue":"3","key":"2024122313404905000_bib26","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.0900477","article-title":"Effects of low-dose aspirin on acute inflammatory responses in humans","volume":"183","author":"Morris","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"2024122313404905000_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bph.15966","article-title":"Fifty years with aspirin and platelets","volume":"180","author":"Patrono","year":"2023","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2024122313404905000_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/pds.3463","article-title":"Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population","volume":"23","author":"Zhou","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"2024122313404905000_bib29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11239-022-02669-7","article-title":"A\u00a0survey of internists' recommendations for aspirin in older adults and barriers to evidence-based use","volume":"54","author":"Schaefer","year":"2022","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"6","key":"2024122313404905000_bib30","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/j.japh.2020.08.002","article-title":"Identification of undocumented over-the-counter medications in an academic nephrology clinic","volume":"60","author":"Kokaly","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/24\/6207\/2346102\/blooda_adv-2024-014220-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/24\/6207\/2346102\/blooda_adv-2024-014220-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T13:40:59Z","timestamp":1734961259000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/24\/6207\/518101\/Guideline-concordance-of-aspirin-use-for-primary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":30,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024,12,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024014220","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]}}}